MTOR and renal cell carcinoma: Centrosomal protein 55 (CEP55) and Annexin A5 promote EMT by activating the PI3K/AKT/mTOR pathway and enhancing the migration and invasion of RCC cells (Chen et al., 2019; Tang et al., 2017).